An update from Gamida Cell Ltd (GMDA) is now available.
Gamida Cell Ltd. has initiated a voluntary restructuring process with backing from Highbridge Capital Management LLC to overhaul its debt and equity structure. This move, aimed at streamlining operations and securing the company’s future, will result in the cancellation of existing shares and the company’s transition to private ownership under Highbridge. Additionally, the company plans to reduce its workforce by 25% to conserve financial resources. The restructuring is also tied to the performance of the company’s product, Omisirge®, with potential future payouts to shareholders based on sales milestones.
For an in-depth examination of GMDA stock, go to TipRanks’ Stock Analysis page.
